Diagnostic blood test for osteoporosis moves a step closer
نویسندگان
چکیده
منابع مشابه
Gene Therapy for Type 1 Diabetes Moves a Step Closer to Reality
The prevalence of diabetes mellitus (DM) is assuming pandemic proportions and is currently estimated at 285 million cases (1). Although most cases are due to obesity-associated type 2 DM, there is also an increase in the annual prevalence of type 1 DM (2). It is estimated that 10% of the diabetic population have type 1 DM. Both forms of DM are associated with a long-term risk of microvascular a...
متن کاملMLL5 governs hematopoiesis: a step closer.
MLL5 is an MLL family protein and a candidate tumor suppressor located within the human chromosome band 7q22 that is frequently deleted in myeloid malignancies. In this issue of Blood, 3 independent studies report the first genetic analysis of MLL5 deficiency in mice. All 3 strains of MLL5 knockout mice exhibited defects in hematopoiesis, highlighting the critical role of MLL5 in hematopoietic ...
متن کاملOne Step Closer towards a Realistic Model for Parallel Computation
We present a new model of parallel computation|the LogGP model|and use it to analyze a number of algorithms, most notably, the single node scatter (one-to-all personalized broadcast). The LogGP model is an extension of the LogP model for parallel computation CKP + 93] which abstracts the communication of xed-sized short messages through the use of four parameters: the communication latency (L),...
متن کاملCathI - Training System for PTCA. A Step Closer to Reality
The number of minimally invasive cardiological interventions has increased over the last few years and therefore computer based training systems find growing interest. They offer a better learning schedule compared to traditional master-apprentice models due to the repeatability of the learning situation and the possibility to learn individual tasks. Below we present the research system CathI t...
متن کاملA step closer toward therapies for p63-related disorders
Small molecules with low molecular weight are of interest for drug development, as they are more likely to be absorbed. In cancer research, p53 is often mutated in many tumors, and many small molecules targeting mutant p53 have been tested. One of such low molecular weight compounds is APR246/PRIMA-1(MET) that was identified as a compound targeting and reactivating p53 mutants based on a cell-b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Endocrinology
سال: 2014
ISSN: 1759-5029,1759-5037
DOI: 10.1038/nrendo.2014.10